D-Tails Srl SB is an Italian Benefit Corporation rooted in over thirty years of scientific and entrepreneurial experience. Its origins date back to Crisel Instruments, followed by CrestOptics, and today, D-Tails, founded by Vincenzo Ricco, together with a consolidated team of engineers who form the company’s technological core, as well as expertise in finance and management.
In 2015, a strategic collaboration with the Italian Institute of Technology (IIT) resulted in the creation of a JointLab, a platform for advanced research in biomedical imaging and diagnostics, which remains operational to this day.
At the end of 2021, D-Tails was established as a spin-off of CrestOptics. In May 2023, it formally became a Benefit Corporation under Italian law, embedding ESG principles into its bylaws and reaffirming its mission: advancing research on the early detection of Alzheimer’s disease and developing noninvasive diagnostic technologies for breast and prostate cancer. D-Tails is driven by scientific curiosity and the conviction that research generates long-term value for society. Its approach connects disciplines and sectors, combining complementary skills and stakeholders in a single vision aimed at fostering knowledge, innovation, and sustainable impact.